SMAD2 and colorectal cancer: Combined with the inhibition of membrane-bound TGF-β1 by NRP2 targeting siRNA (Figure S5), these results supported the hypothesis of a direct binding activity of TGF-β1 by NRP2 leading to smad2/3 phosphorylation in colorectal cancer cells.